| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cibus, Inc. (CBUS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CBUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 894.3K | $1.22M | - | |
| CEO | 686.8K | $934.1K | - | |
| VP | 422.9K | $575.1K | - | |
| Other | 167.9K | $228.3K | - | |
| CFO | 154.3K | $209.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2020 | Dumont Philippe | Director | Sell | 236 | $7.60 | $1,793.60 | -11.8% | |
| Oct 2, 2019 | Dumont Philippe | Director | Sell | 236 | $4.96 | $1,170.56 | -10.6% | |
| Oct 2, 2019 | Kozicz-Stankiewicz Anna Ewa | Director | Sell | 245 | $4.96 | $1,215.20 | -5.9% | |
| Jul 18, 2019 | Dumont Philippe | Director | Sell | 706 | $10.00 | $7,060.00 | -24.0% | |
| Jul 18, 2019 | Kozicz-Stankiewicz Anna Ewa | Director | Sell | 735 | $10.00 | $7,350.00 | -15.1% | |
| Jul 1, 2019 | Sahoo Manoj | Chief Commercial Officer | Sell | 1,494 | $12.70 | $18,967.08 | -2.2% | |
| Apr 29, 2019 | Voytas Daniel F | Chief Science Officer | Sale+OE | 3,750 | $16.31 | $61,152.38 | -3.9% | |
| Apr 2, 2019 | Blome James | Chief Executive Officer | Sell | 2,582 | $16.65 | $42,982.04 | -1.6% | |
| Apr 1, 2019 | Sahoo Manoj | Chief Commercial Officer | Sell | 1,522 | $17.33 | $26,378.09 | -2.2% | |
| Mar 26, 2019 | Blome James | Chief Executive Officer | Sell | 2,582 | $17.87 | $46,128.98 | -1.6% |